Contact

Please use this form to send email to PR contact of this press release:
KAER Biotherapeutics Awarded NIH Grant to develop SUPRAERĀ® Surfactant Aerosol Therapy for Neonatal Respiratory Distress

TO:
Donovan Yeates, CEO
KAER Biotherapeutics
+1 760-480-9400

FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image